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Abstract 
Estrogen (E2) plasma levels fluctuate as a function of estrous cycling in the 
mouse. Apolipoprotein E (apoE) mRNA has been shown to increase in both hippocampal 
astrocytes and microglia during proestrus when plasma estrogen levels are high. The 
current study was designed to evaluate apoE localization and glial activation in mouse 
olfactory bulb (OB) as a function of the estrous cycle. In the rat OB, estrogen receptor~ 
(ER~) is present in the glomerular and external plexiform layers, but not the internal 
plexifonn and granule cell layers. Normal female mice 2-3 months old at the start of the 
study were evaluated by vaginal smears for at least three weeks to assure normal estrous 
cycles. Three mice were sacrificed during diestrus, proestrus or estrus. The OB were 
collected and fixed for immunocytochemical techniques. Immunoreactive cell counts 
were made for apoE, glial fibrillary acidic protein (GF AP), an antigen elevated by 
activated astrocytes, and F4/80, an antigen elevated by activated microglia. Our studies 
found that estrus stage affected overall density of immunoreactive glial cells. ApoE levels 
covaried with E2 levels in the estrous cycle. During estrus, when E2 levels are declining, 
astrocyte immunoreactivity was highest in the glomerular, internal plexiform and granule 
cell layers suggesting a somewhat delayed response to E2. During proestrus and diestrus, 
when E2 levels are increasing, microglial density increased in the internal plexiform and 
granule cell layers suggesting a more immediate E2 effect. These data suggest that 
microglia and astrocytes respond to E2 in a time-dependent manner that is mediated 
through ER~ and other sequential cellular mechanisms. 
Introduction 
ApoE is a 299 amino acid, 34-kDa lipid transport protein that functions in 
utilization and redistribution of lipids [Pitas et al, 1987a, 1987b ]. ApoE exists as three 
isoforms in humans (E2, E3, and E4) [Mahley et al., 1996], and is expressed from 
multiple alleles at a single genetic locus on chromosome 19 [Saunders et al., 1993; 
Beffert et al., 1998]. Current research has concluded that possession of the apoE4 allele is 
a major risk factor for the development of Alzheimer's disease (AD) [Hyman et al., 1996; 
Mahley et al., 1996; Saunders et al., 1996]. The protein is synthesized in astrocytes and 
microglia and secreted into the neuropil for neuronal uptake. In brief, apoE mediates the 
binding oflipid particles to lipoprotein receptors [Kowal et al., 1990; Mahley, 1988]. 
Subsequent to binding, the apoE-lipoprotein complex is internalized for utilization of the 
lipoprotein in cellular metabolic processes such as synaptic remodeling and the regulation 
of plasma cholesterol [Pitas et al., 1987a]. Control of this protein is undoubtedly 
important in efficient utilization of lipids in cell functioning. 
AD is characterized by cognitive decline and a progressive loss of synaptic 
connections in the brain. In humans, there are three types of AD: early-onset familial 
(<65 yrs) and late-onset familial (>65 yrs), which occurs in patients with a family history 
of AD; and late-onset sporadic (>65 yrs) which occurs in patients without a family 
history of AD. Estrogen loss that women experience during menopause is considered a 
major risk factor for developing AD. In fact, 2 out of 3 AD patients are women. 
Therefore, estrogen loss combined with apoE genotype places women at great risk for 
developing AD. 
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Previous studies have reported that exogenous E2 elevates apoE message in the 
brain [Srivastava et al., 1996; Stone et al., 1997; Stone et al., 1998]. However, a more 
clear understanding of the functional relationship between endogenous E2 and the glial 
cells responsible for producing apoE remains to be developed. In the mouse, E2 levels are 
highest during proestrus, rapidly decline during estrus, and begin to rise again during 
diestrus. Therefore, it seemed logical to characterize the response of glial cells to 
endogenous E2 level changes observed during the normal estrous cycle in the mouse. 
Microglia and astrocytes are believed to be involved in many functions in the 
nervous system. The phagocytosis of degenerating cells and processes, the removal and 
rearrangement of synaptic connections, and the production of neurotrophic factors 
important during neuroregeneration are just some microglial functions [Nakajima, et al., 
1993, and Rabchevsky, et al., 1998]. Astrocyte processes are believed to define the 
periphery and core of individual glomeruli, the functional unit of the OB [Chiu & Greer, 
1996]. Astrocyte functions may include neurotransmitter removal from the extracellular 
matrix [Keyser & Pellman, 1994] and the regulation of ion concentration gradients within 
the glomerular neuropil [Sontheimer, 1995]. 
The mouse OB is highly laminated structure shown in Figure 1. The superficial-
most layer of the olfactory bulb is the olfactory nerve layer (ONL), which contains axons 
from the primary olfactory neurons and specialized glia referred to as ensheathing glia 
[Ramon-Cueto et al., 1995]. Immediately deep to the ONL is the glomerular layer where 
receptor axons and post-synaptic structures form a relatively large (ca. 80-lOOµm) 
synaptic complex, the glomerulus. The glomerulus is the initial site of synaptic 
integration in the olfactory system. Septae composed of both neural and glial elements 
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separate glomeruli from one another. The glomerular layer, in turn, surrounds the 
external plexiform layer (EPL), a relatively neuron-free zone, which is limited internally 
by the mitral cell layer (MCL). The EPL contains dendrites of mitral cells and other 
tufted neurons whose cell bodies lie in the EPL. The cell bodies of mitral cells form a 
distinct monolayer between the EPL and the internal plexiform layer (IPL), a cell-poor 
zone that, in tum, surrounds the granule cell layer (GCL). Granule cells that comprise this 
layer form densely packed aggregates that are coupled by gap junctions, which may serve 
to synchronize the functional activity of these neurons [Reyher, et al., 1991]. The 
dendrites of the granule cells ramify in the EPL where they synapse on the dendrites of 
mitral cells. At the core of the OB is the ventricular layer (Vent) or subependymal zone 
comprising cells that are migrating from the rostral part of the lateral ventricles. 
In addition, previous studies have shown that nuclear E2 receptors (ERa., ERP) 
are not uniformly distributed in the central nervous system [Shughrue et al., 1997a, 
1997b, 2001]. In the rat OB, ERP is the only receptor subtype that has been reported. The 
current study was designed to evaluate the localization and distribution of apoE and 
activated glia in the mouse OB as a function of the estrous cycle. 
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Procedures 
All procedures in this study were approved by the Eastern Illinois University 
Animal Care Committee and were carried out with strict adherence to the guidelines set 
out in the NIH guide for the care and use of laboratory animals. Normal female mice 2-3 
months old at the start of the study were evaluated by vaginal smears for at least three 
weeks to assure normal estrus cycles. Three mice were sacrificed during diestrus, 
proestrus or estrus. For sacrifice, the mice were anesthetized with pentobarbital 
(1 OOmg/kg) I.P. and perfused with ice-cold 4% paraformaldehyde in 0.1 M phosphate 
buffer, pH= 7.4. The cold brain was then removed from the skull case, immersed in 30% 
sucrose in O. lM phosphate buffer overnight, and frozen with dry ice for subsequent 
analysis. Three male mice, aged 2-3 months, were also sacrificed and brains harvested as 
described above. 
Immunohistochemistry Techniques 
Three mice from each condition were available for analysis. Thirty-micrometer 
sections were cut from fixed-frozen olfactory bulbs on a freezing microtome and 
prepared as previously described [Struble et al., 1998; Nathan et al., 2001]. Briefly, 
sections were collected in 0. lM phosphate buffered saline (0.9% NaCl, PBS), pH= 7.4. 
Sections were incubated in 0.5% hydrogen peroxide in methanol for 30 min to block 
endogenous peroxidases. Nonspecific binding was decreased with 5% Carnation Instant 
dried milk in PBS containing 1 % TX for lh. Block was followed by incubation with the 
following primary antisera/bodies for 48h in PBS with 0.1 % TX and dried milk: a) human 
anti apoE goat antiserum (1 :4000 dilution Calbiochem), b) mouse anti f 4/80 (1 :400 
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dilution; Serotec), an antigen elevated by activated microglia [Andersson et al., 1998] or 
c) mouse anti-glial fibrillary acidic protein (GFAP) (1 :8000 dilution; Accurate), to 
identify intermediate filaments in activated astrocytes. After incubation with the primary 
antibodies/sera sections were incubated with rabbit anti-goat or goat anti-mouse sera 
(Cappel; 1 :200 dilution) and then goat or mouse peroxidase-antiperoxidase complex 
(Sternberger-Meyer; 1 :200 dilution). Bound apoE and GF AP antibodies were visualized 
with diaminobenzidine (DAB) (5mg/10ml PBS) development that resulted in a brown 
reaction product. F4/80 antibodies were visualized by avidin-biotin technique (Vecta 
Stain kit). 
Sections of the OB were removed from PBS solution and mounted directly onto 
subbed slides. The sections were dehydrated through a graded series of alcohols, cleared 
in xylene, and coverslipped. Sections selected from the midportion of the OB were 
selected for quantitation. 
Plotting of immunoreactive cells in these sections was performed with 
Neurolucida®, which permits operator selection of marked objects on a live microscopic 
image. All measurements were recorded on the same day at the same light intensity while 
blinded to the estrous stage. Lamina were outlined at low power (2X objective) and each 
immunostained perikarya was then marked at a higher power (1 OX objective). Cell 
density was obtained by dividing cell counts by laminar area. 
Data Analysis 
Density data from these studies were initially analyzed by a repeated measures 
analysis of variance with estrous phase as the independent measure and laminae as the 
repeated measure. If statistical significance was obtained for the interaction term of 
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"lamina by estrous phase", a one-way analysis of variance was performed to determine 
which lamina varied as a function of the estrous cycle. 
Results 
ApoE immunoreactivity was comparable to that described previously in the 
mouse and human olfactory bulb (Struble et al., 1999). ApoE-like immunoreactivity was 
generally found outlining the large fascicles of the ONL and surrounding glomeruli in the 
glomerular layer (Fig. 2). Immunoreactivity in the EPL was less intense than the 
periglomerular region with the external portion adjacent to the glomerular layer 
displaying the most intense immunostaining (Fig. 3). Most cellular immunoreactivity 
appeared to be in glia. 
During the estrus stage, diffuse apoE immunoreactivity appeared to be elevated in 
the glomerular layer and EPL. However, statistical analysis of cell density found no 
differences among estrous phases (F=0.292, df=2,5, N.S.). A significant laminar 
difference was found, (F=22.756, df=4,20, p<0.001) irrespective of estrous phase. The 
glomerular layer and GCL/IPL had a higher cell density than did the EPL or ventricular 
layer (Fig. 4). The interaction between lamina and estrous phase was not significant 
showing that cell density did not change in any lamina as a function of estrous phase 
(F=O. 922, df=8,20, p<0.519). 
In the glomerular layer, F4/80 immunoreactivity was distributed uniformly (Fig. 
5). Activated microglia were evident within the IPL and GCL and little to no 
immunoreactivity was seen in the MCL. During the diestrus stage, the number off 4/80 
immunoreactive cells was elevated in the GCL when compared to the other stages (Fig. 
6a). IPL expression was somewhat elevated in proestrus compared to the other phases 
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(Fig. 6b ). Statistical analysis of total cell density found no differences among estrous 
phases (F=l .092, df=2,5, N.S.). A significant laminar difference was found, (F=l 76.740, 
df=4,20, p<0.001). Among all stages, the glomerular layer and EPL/IPL had a higher cell 
density than did the GCL or ventricular layer. The interaction between lamina and estrous 
phase was significant showing that cell density changed in a laminar-specific manner as a 
function of estrous phase (F=3.022, df=8,20, p<0.021). 
One-way analysis of variance for each lamina showed that the GCL reached 
significance (F=13.209, df=2,5; p<0.010). Inspection showed that immunoreactive cell 
density was higher on diestrus than on the other two phases of the estrous cycle. This 
density increase can be appreciated from the plots of immunoreactive cells in Figure 7. A 
one-way analysis of variance for the IPL also approached significance (F=3.501, df=2,6; 
p<0.098). No significance was found in other lamina. 
GF AP immunoreactivity was comparable to that described previously in the rat 
olfactory bulb (Bailey, et al., 1993). Astrocyte distribution and density of GF AP 
immunoreactivity was distinctive for each of the layers of the olfactory bulb (Fig. 8). In 
the glomerular layer, astrocytes were organized periglomerularly (Fig. 9a). In the EPL, 
astrocytes were spaced relatively uniformly. In the IPL/GCL, immunoreactive astrocytes 
outlined granule cell aggregates coupled by tight junctions (Fig. 9b ). 
Analysis of variance showed a non-significant effect of estrous phase on density 
of total GFAP immunoreactive cell density (F=4.616; df=2,6; p<0.061). A clear laminar 
effect was found (F=41.285; df=4,24, p<0.001). The IPL and glomerular layer had a 
higher density than did EPL and GCL/ventricular layer. Perikarya were distributed 
uniformly within the IPL, GCL, and ventricular layer. Distribution was periglomerular 
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within the glomerular layer. These distributions can be appreciated from the plots of 
immunoreactive cells in Figure 10. Cell density changed within specific lamina as a 
function of estrous phase, the interaction between lamina and estrous phase reaching 
significance (F=2.841, df=8,24, p<0.023). 
One-way analysis of variance for each lamina found that the glomerular layer 
approached significance (F=4.695, df=2,6; p<0.059). Inspection showed that 
immunoreactive cell density was highest on estrus than on the other two phases of the 
estrous cycle. Analysis of variance for EPL, IPL, and ventricular layer each was non-
significant (F=0.983, df=2,6; p<0.427; F=3.157, df=2,6; p<0.116; and F=3.506, df=2,6; 
p<0.098 respectively). In sum, this analysis suggested that the greatest change in GF AP 
cell density with the estrous cycle was found in the glomerular layer. 
Male mice showed laminar distributions for apoE, F4/80, and GF AP that were 
much more uniform than patterns seen in the female mice. For each antibody, male cell 
densities were always lower than the female estrous phase with the highest cell densities. 
However, male expression was never lower than the estrous phase, which expressed the 
lowest cell densities. This would suggest a baseline level of male glial expression that 
falls somewhere in the mid-range of female expression. 
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Discussion 
This study demonstrates that estrous stage affects the level of activation of glial 
cells in the OB. Glial activation was manifested as changes in cell density at different 
stages of the cycle. Changes in cell density demonstrate neuronal plasticity in the mouse 
olfactory system as a function of normal E2 fluctuations. 
Microglial expression was significantly elevated during diestrus in the granule 
cell layer, and approached significance during proestrus in the internal plexiform layer. In 
the rat, it has been shown that these lamina may not contain ERp. Also, E2 levels are 
rising during diestrus and proestrus. Activation of glia in these areas suggests an E2 
stimulation corresponding to increasing levels of E2. This stimulation may be mediated 
through mechanisms secondary to changes in OB primary neurons or through a non-
genomic mechanism as has been reported for some actions of estradiol [see Toran-
Allerand et al, 1999; McEwen et al, 2001]. For example, transynaptic regulation could 
occur via changes in mitral cell axons or modulations in mitral and granule cell synaptic 
activity. 
GF AP immunoreactivity was elevated in estrus with astrocytes abundant in the 
glomerular, internal plexiform, and granule cell layers when compared to the other 
phases. Only the glomerular layer, which has been shown to contain ER~, approached 
significance. Low levels of E2 characterize the estrus phase, and therefore; astrocyte 
activation in response to E2 stimulation appeared to be delayed compared to microglial 
activation. Although the mechanism of activation is still unclear, E2 stimulation of ERP 
may cause a cell-signal cascade responsible for the sequential activation of astrocytes and 
microglia in the glomerular, internal plexiform, and granule cell layers. Jn vitro research 
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has shown that heterotypic cultures of astrocytes and microglia are required to elicit a 
response to E2 treatment (Stone et al., 1997). In vivo, glial cells may require intercellular 
communication for activation and production of apoE. 
In the rat, hippocampal and hypothalamic regions have been shown to contain 
both ER a and ERP subtypes [Shughrue et al., 1997 a, 1997b, 2001]. Previous studies 
examining these regions have shown that apoE mRNA increased in both astrocytes and 
microglia during proestrus when plasma E2 was high and synaptic density was increasing 
[Stone et al., 1997]. This change however was not identified in the CA3 hippocampal 
region. Using immunoblotting techniques, our laboratory has found apoE levels are 
highest on proestrus in the hippocampus, cingulate cortex and frontal cortex. In contrast, 
apoE was highest on estrus in the olfactory bulb and cerebellum. In the OB, ERP is 
exclusively expressed [Shughrue et al., 1997a, 1997b, 2001]. This would suggest that E2 
stimulation via ERP can elevate apoE levels in the OB. However, elevation requires 
several days after peak E2 concentration, which suggests an intermediate step in apoE 
production, such as glial activation. 
Our laboratory has shown that total OB apoE concentrations were highest in 
estrus and diestrus and lowest in proestrus using western blot. Histological analysis failed 
to support this finding. The apoE staining produced a diffuse brown product, which 
resulted in very few visible perikarya or glia. An explanation for this histological 
discrepancy could be the rapid translocation of apoE from glia to the neuropil where it is 
internalized by neurons and rapidly degraded. Immunoblotting techniques were able to 
detect protein levels in the homogenized bulb. Immunocytochemical plotting techniques 
were limited to the quantification of immunoreactive perikarya, which proved well below 
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blotting values. This would suggest that intraneuronal apoE concentration in vivo is 
below the threshold of detectability by immunocytochemical techniques. 
A previous study has shown that the activation of glial cells takes place 
sequentially following nerve injury. Using trimethyl tin-induced neurodegeneration, 
McCann and colleagues found significant increases in the expression of GF AP in the rat 
septum, hippocampus, olfactory bulb, and pyriform cortex after microglial activation was 
already underway. Therefore, microglial activation precedes astrogliosis in response to 
trimethyl tin-induced neuronal necrosis (McCann, et al., 1996). Understanding the 
mechanisms of glial activation will no doubt shed light on the production of apoE. 
Post-menopausal women experience a cessation of E2 production and have been 
shown to exhibit cognitive decline. If predisposed to AD, neurodegeneration may also 
take place in these women. Since apoE genotype can significantly affect developing AD 
[Paganini-Hill & Henderson, 1994; Brenner et al, 1994; Tang et al, 1996], understanding 
the relationship between apoE and E2 is clinically relevant. Some studies have suggested 
that hormone replacement therapy (HRT) can improve cognition in post-menopausal 
women. Numerous studies have reported that HRT decreases the risk for developing 
dementia by about 2-3 fold. HRT is also associated with a later onset and less malignant 
course of Parkinson's disease [Mayeux et al, 1995; Kuopio et al, 1999; Saunders-Pullman 
et al, 1999], and a decreased risk or better prognosis following stroke [Paganini-Hill, 
1995]. 
We have speculated that apoE may be involved in repair and recycling of 
membrane materials [Nathan et al, 2001]. Consistent with this postulate a previous study 
has shown that increased synaptic sprouting in response to estrogen is mediated by apoE 
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[Stone et al, 1998]. Numerous factors combine to affect the expression of apoE. Some 
data suggest that apoE may be modulated at the levels of secretion, translation and 
transcription [Ignatius et al, 1986; Werb et al., 1986]. It has been suggested that 
individuals with an apoE4 allele are unable to compensate as well as apoE3 individuals 
for age-related neuronal cell loss by synaptic remodeling [Cambon et al., 2000]. This 
deficiency may be related to either the quantity or functionality of apoE produced. 
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Figure I - (4X objective) Laminar organization of olfactory bulb. Coronal midsection of olfactory bulb 
stained for GFAP emphasizing lamination. Ventricular zone (vent), also known as the subependymal zone, 
forms a dark-staining line through the core of the bulb, which, in tum is surrounded by the granule cell 
layer (gel). The internal plexiform layer (ipl) forms a distinct thin layer sandwiched between the gel and 
mitral cell layer (me!). The arrowheads mark the mcl. The external plexiform layer (epl) is a relatively cell-
poor layer contained between the me! and the glomerular layer (glom). The glomerular layer contains the 
functional units of the olfactory system, the glomeruli. The bar represents 500µm. 
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Figure 2 - (4X objective) Olfactory bulb stained for apoE. Note the periglomerular distribution of apoE 
immunoreactivity marked by the arrows. The bar represents 500µm . 
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Figure 3 -(IOX objective) Higher power view ofapoE immunoreactivity. External and internal plexiform 
layers exhibit diffuse immunoreactivity that appears elevated in the estrus stage (A) when compared to 
diestrus (B) or proestrus (not shown). Very few immunoreactive perikarya are visible due to diffuse apoE 
staining. The large fascicles of olfactory nerve layer show considerable apoE immunoreactivity. 
Periglomerular distribution of apoE immunoreactivity (marked by the arrows) can be visualized well in B. 
The bar represents I 00 µm. 
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Figure 4 - Neurolucida plotting of apoE immunoreactive perikarya. During estrus (B) the glomerular layer 
shows an increase in immunoreactive perikarya. With the exception of the glomerular layer, proestrus (A) 
and diestrus (C) stages exhibit laminar cell densities similar to estrus. 
11 
Figure 5 -(4X objective) Coronal midsection of bulb stained for F4/80 . Activated microglia are spaced 
uniformly throughout the glomerular, internal plexiform and granule cell layers. External plexiform layer 
immunoreactivity is less pronounced than in surrounding lamina. 
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Figure 6a - (1 OX objective) Laminar differences in relative density of F4/80 expression during the estrous 
cycle. The mitral cell layer displays almost no F4/80 immunoreactivity. Perikarya are distributed uniformly 
within the granule cell layer and cell density appears relatively low in estrus (A) when compared to diestrus 
(B ). The bar represents I OO~tm. 
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Figure 6b - (IOX objective) Laminar differences in relative density ofF4/80 expression throughout the 
estrous cycle. Numerous immunoreactive perikarya can be seen in all layers of the olfactory bulb. With the 
exception of the GCL, the overall intensity of labeling is more pronounced during proestrus (A) in all 
lamina. Estrus phase (B) displays the smallest density ofperikarya in all lamina when compared to the 
other phases, which may suggest a timeframe for baseline levels ofF4/80 immunoreactivity. The bar 
represents I OOµm . 
24 
Figure 7 - Neurolucida plotting of F4/80 immunoreactive perikarya. Perikarya are evenly distributed 
throughout the lamina. Proestrus phase (A) shows an increase in perikarya in the internal plexiform layer. 
The lowest cell densities are seen during the estrus phase (B). During diestrus (C), perikarya expression is 
increased in the granule cell layer. The bar represents I OOµm. 
25 
Figure 8 -(4X objective) Whole bulb distribution ofGFAP immunoreactivity. Activated astrocytes are 
located periglomerularly within the glomerular layer. Cell distribution is uniform throughout the internal 
plexiform and granule cell layers. External plexiform layer immunoreactivity is less pronounced than in 
surrounding lamina. The bar represents 500µm . 
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Figure 9a - (I OX objective) Laminar differences in relative density of GF AP expression throughout the 
estrous cycle. GF AP immunoreactivity is evident in the fascicles of the olfactory nerve layer, Perikarya are 
distributed evenly within the Glom and an increase in expression during estrus (B) is evident when 
compared to proestrus (A) and diestrus (not shown here). EPL contains very few immunoreactive 
perikarya. The bar represents I OOµm. 
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Figure 9b - (I OX objective) Laminar differences in relative density of GF AP expression throughout the 
estrous cycle. Estrus (A) clearly exhibits a greater density of immunoreactive perikarya when compared to 
diestrus (B). Perikarya are evenly distributed and expression increases during estrus within the granule cell 
and internal plexiform layers. The bar represents IOOµm. 
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Figure I 0 - Neurolucida plotting of G F AP immunoreactive perikarya. Perikarya distribution is 
periglomerular within the glomerular layer. Cell density is evenly distributed within the other lamina. 
Estrus phase (8) shows an increase in perikarya in the glomerular layer. Diestrus phase (C) exhibits the 
lowest laminar densities when compared to proestrus (A) and estrus, which may represent baseline GF AP 
immunoreactivity. Cell density also appears to increase in the granule cell and internal plexiform layers 
during estrus. The bar represents IOO~tm. 
29 
